TP53 and hepatocellular carcinoma: For example, it has been demonstrated that TRIM22-mediated degradation of PHLPP2 results in the activation of AKT-p53-p21 signaling, which ultimately induces cellular senescence in hepatocellular carcinoma cells [119].